Background
National Seating & Mobility, Inc. provides customized wheelchairs and other durable medical equipment (DME) to Medicaid recipients. In December 2020, the New York State Office of the Medicaid Inspector General (OMIG) notified the company that it would audit a random sample of 160 Medicaid claims submitted during calendar years 2015 through 2017. During that period, the company had filed 1,586 claims totaling approximately 89,000. OMIG reviewed the 160 sampled claims and identified 110 as improperly documented: the company had failed to obtain original signed orders from prescribing practitioners as required by New York’s Medicaid Durable Medical Equipment Manual Policy Guidelines.
OMIG applied statistical extrapolation to the sample findings and calculated a total overpayment of approximately 70,000, later reduced to 51,393 at settlement. After an administrative hearing in which the company challenged the audit methodology, the documentary requirements, and the fairness of full recoupment, an Administrative Law Judge upheld OMIG’s determinations. The company commenced a CPLR Article 78 proceeding, which Supreme Court transferred to the Third Department for direct review.
The Court’s Holding
The Third Department confirmed OMIG’s determination across all challenged grounds. First, the company argued that OMIG had improperly enforced the DME Policy Guidelines without complying with the State Administrative Procedure Act (SAPA)’s rulemaking requirements — specifically, that the guidelines should have been promulgated as formal rules subject to notice and comment. The court held this argument was unpreserved because it was raised for the first time in the reply brief at the administrative level, not at the hearing itself. But the court went on to address the merits: the DME Policy Guidelines are “interpretive statements” that explain what kinds of documentation satisfy an existing regulatory requirement (18 NYCRR 505.5[a][8]) — they do not impose new obligations of their own and therefore are exempt from SAPA’s rulemaking procedures.
On the merits, the court reviewed the hearing record under the substantial-evidence standard. The disputed documentation problem was specific: for each of the 110 flagged claims, the company received a faxed, signed order that originated when the company sent a proposed order to the practitioner by fax, the practitioner signed it and faxed it back. OMIG determined these were “signed written orders” — not “electronically transmitted fiscal orders” — because they did not originate from the practitioner’s computer. Under the DME guidelines in effect during the audit period, a signed written order that was transmitted by fax required the DME provider to obtain the original document bearing a “wet signature” from the practitioner within 30 calendar days. The company produced no original wet-signed orders. The court found substantial evidence supported OMIG’s disallowances.
The company also argued that a 2021 amendment to the DME guidelines — which removed the wet-signature requirement for faxed orders but added validation steps — revealed that the earlier guidelines had been arbitrary. The court rejected this: the old and new guidelines each addressed fraud-prevention in a reasonable way. The company’s final argument — that full recoupment was unfair because the underlying equipment was actually delivered to patients — also failed. The court confirmed that Medicaid overpayment recoupment is not a sanction but a remedy, and providers are liable for repayment of any amount not authorized under the program, even when the underlying service was rendered.
Key Takeaways
- OMIG’s DME Policy Guidelines are interpretive statements, not rules, and are not subject to SAPA rulemaking requirements; they merely explain what documentation satisfies existing regulations.
- A faxed signed order that originated from the DME provider’s fax — not from the practitioner’s computer — is a “signed written order,” not an “electronically transmitted fiscal order,” and therefore required an original wet-signed document within 30 days under pre-2021 guidelines.
- Medicaid overpayment recoupment is not a penalty subject to a “shocking to one’s sense of fairness” review — it is a straightforward remedial remedy regardless of whether the underlying services were actually rendered.
- Administrative arguments not raised at the ALJ hearing — including SAPA challenges to policy guidelines — are unpreserved for appellate review.
Why It Matters
DME providers across New York submit thousands of Medicaid claims relying on faxed practitioner orders. This decision clarifies the documentation fault line: whether a faxed order counts as an “electronically transmitted fiscal order” (no wet signature required) or a “signed written order” (original required within 30 days) turns on where the order originated. If the DME provider created the template and sent it to the practitioner for signature, the result is a signed written order that triggered the wet-signature requirement during the audit period — and potentially exposes the provider to full recoupment of all claims in the sample.
Although the 2021 guideline revision relaxed the wet-signature rule, providers still need to meet the validation requirements in the current guidelines. Healthcare counsel and compliance officers at DME companies should audit current order-intake workflows to confirm compliance with the post-2021 standards, and should note that full recoupment — not a proportional penalty — is the remedy for non-compliant documentation, regardless of whether patients received the equipment. Providers facing OMIG audits should also ensure that all SAPA and procedural objections are raised at the administrative hearing stage, not later.